Takeda Pharmaceutical
TAK
#424
Rank
โ‚ฌ44.11 B
Marketcap
13,93ย โ‚ฌ
Share price
-0.59%
Change (1 day)
8.29%
Change (1 year)

Revenue for Takeda Pharmaceutical (TAK)

Revenue in 2024 (TTM): โ‚ฌ27.80 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current revenue (TTM ) is โ‚ฌ27.74 Billion. an increase over the revenue in the year 2023 that were of โ‚ฌ26.54 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Takeda Pharmaceutical from 2009 to 2024

Annual revenue

Year Revenue Change
2024 โ‚ฌ28.80 B8.49%
2023 โ‚ฌ26.54 B-3.78%
2022 โ‚ฌ27.59 B0.95%
2021 โ‚ฌ27.33 B11.41%
2020 โ‚ฌ24.53 B-7.47%
2019 โ‚ฌ26.51 B87.86%
2018 โ‚ฌ14.11 B6.48%
2017 โ‚ฌ13.25 B-12.91%
2016 โ‚ฌ15.21 B9.72%
2015 โ‚ฌ13.87 B4.77%
2014 โ‚ฌ13.23 B9.64%
2013 โ‚ฌ12.07 B-17.04%
2012 โ‚ฌ14.55 B2.12%
2011 โ‚ฌ14.25 B15.46%
2010 โ‚ฌ12.34 B13.94%
2009 โ‚ฌ10.83 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ82.23 B 196.34%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ44.40 B 60.01%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ58.90 B 112.28%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ47.88 B 72.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ2.12 B-92.33%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.42 B-87.65%๐Ÿ‡ฎ๐Ÿ‡ณ India
โ‚ฌ30.94 B 11.51%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ37.20 B 34.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ59.40 B 114.09%๐Ÿ‡บ๐Ÿ‡ธ USA